Results 221 to 230 of about 17,165 (261)
Some of the next articles are maybe not open access.
Nebulized albuterol in acute bronchiolitis
The Journal of Pediatrics, 1990In a double-blind, placebo-controlled trial, 40 infants between 6 weeks and 24 months of age who had a first episode of wheezing and other signs and symptoms of bronchiolitis were randomly assigned to receive either nebulized albuterol (0.15 mg/kg/dose) or placebo (saline solution) for two administrations 1 hour apart. The albuterol therapy resulted in
Eitan Kerem +6 more
openaire +2 more sources
Allergy and Asthma Proceedings, 2016
BACKGROUND Albuterol multidose dry powder inhaler (MDPI) with an integrated dose counter allows patients to track the number of remaining doses and to simplify dosing by eliminating the need to coordinate inhalation with actuation associated with metered-
J. Given, H. Taveras, H. Iverson
semanticscholar +1 more source
BACKGROUND Albuterol multidose dry powder inhaler (MDPI) with an integrated dose counter allows patients to track the number of remaining doses and to simplify dosing by eliminating the need to coordinate inhalation with actuation associated with metered-
J. Given, H. Taveras, H. Iverson
semanticscholar +1 more source
Unusual Vascular Reactions to Albuterol
Archives of Internal Medicine, 1984Two patients experienced previously undescribed vascular reactions to albuterol sulfate inhalation. Features of the first reaction suggest mast-cell degranulation and were reversed by epinephrine. The second patient experienced severe postural hypotension corresponding to albuterol's duration of action.
Michael A. Passero, Alan Shurman
openaire +3 more sources
American Journal of Health-System Pharmacy, 2016
PURPOSE The results of a study to assess the financial impact of an automatic formulary substitution of ipratropium-albuterol nebulization solution for ipratropium-albuterol metered-dose inhalers (MDIs) at an academic health system are reported ...
Steven M Loborec +2 more
semanticscholar +1 more source
PURPOSE The results of a study to assess the financial impact of an automatic formulary substitution of ipratropium-albuterol nebulization solution for ipratropium-albuterol metered-dose inhalers (MDIs) at an academic health system are reported ...
Steven M Loborec +2 more
semanticscholar +1 more source
Unintentional albuterol ingestion in children
Pediatric Emergency Care, 1994This study was designed to determine the threshold dose for toxicity, the potential for serious medical complications, and the medical care required after unintentional albuterol ingestion in children. This study was prospective and descriptive. Data were obtained on pediatric albuterol ingestions evaluated emergently as reported to three regional ...
Douglas J. Borys +3 more
openaire +3 more sources
Albuterol syrup in the treatment of asthma
Journal of Allergy and Clinical Immunology, 1985This study evaluated the administration of albuterol syrup (0.1 mg/kg/6 hr) or placebo to 2- to 6-year old children whose extrinsic asthma was treated with maintenance theophylline in a prerandomized, double-blind crossover study design. Albuterol/theophylline treatment produced peak expiratory flow rates 2 hours after administration that were ...
William E. Pierson +7 more
openaire +3 more sources
Pediatric Critical Care Medicine, 2015
Objectives: Continuous albuterol nebulization is generally administered at 2.5–20 mg/hr at most centers. We examined the effect of high-dose (75 or 150 mg/hr) albuterol on clinical variables in children with status asthmaticus.
Suwannee Phumeetham +3 more
semanticscholar +1 more source
Objectives: Continuous albuterol nebulization is generally administered at 2.5–20 mg/hr at most centers. We examined the effect of high-dose (75 or 150 mg/hr) albuterol on clinical variables in children with status asthmaticus.
Suwannee Phumeetham +3 more
semanticscholar +1 more source
Diastolic hypotension in pediatric patients with asthma receiving continuous albuterol
Journal of Asthma, 2015Objectives: Concerns have been raised regarding cardiac side effects of continuous high-dose albuterol nebulization in status asthmaticus management. Our study goal was to determine prevalence and potential risk factors for hypotension development during
Sarah Wisecup +4 more
semanticscholar +1 more source
Contrasting properties of albuterol stereoisomers☆☆☆
Journal of Allergy and Clinical Immunology, 1999Racemic albuterol is composed of an equimolar mixture of stereoisomers. For asthma therapy, (R)-albuterol is the eutomer and (S)-albuterol is the distomer. By interacting with beta(2 )-adrenoceptors, (R)-albuterol has bronchodilator, bronchoprotective, anti-edematous properties and inhibits activation of mast cells and eosinophils.
John E. Morley, Clive P. Page
openaire +3 more sources
Multiple‐Dose Albuterol Kinetics
The Journal of Clinical Pharmacology, 1986Albuterol a beta‐adrenergic agonist bronchodilator, was studied in 12 healthy male volunteers to evaluate the steady‐state pharmacokinetics following oral administration of 4‐mg tablets, given every six hours for five days. The kinetics of albuterol were best described by a two‐compartment open model with first‐order absorption kinetics.
Menger Chung +6 more
openaire +3 more sources